Blog
Samsung Biologics Completes Spin-Off and Launches Samsung Epis Holdings
On November 3, 2025, Samsung Biologics announced the completion of the spin-off of its investment and subsidiary management business unit, and the establishment of Samsung Epis Holdings, an investment holding company that will oversee Samsung Bioepis and other future biotechnology subsidiaries….
By: Goodwin